Interleukin-5 Antagonist
- Name
- Interleukin-5 Antagonist
- Accession Number
- DBCAT003472 (DBCAT004230)
- Description
Not Available
- Drugs
Drug Drug Description Reslizumab An IL-5 antagonist used as an add-on maintenance treatment of patients with severe eosinophilic asthma in adults. Mepolizumab A fully-humanized monoclonal IgG1 kappa anti-IL-5 antibody used in conjunction with other therapies to treat severe asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome. - Drugs & Drug Targets
Drug Target Type Reslizumab Interleukin-5 target Mepolizumab Interleukin-5 target